The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens

Transplantation

Volumn 77, Issue 8, 2004, Pages 1236-1239

  Dankers, Marlies K A ^a   Witvliet, Marian D ^a   Roelen, Dave L ^a   De Lange, Peter ^a   Korfage, Nelleke ^a   Persijn, Guido G ^b   Duquesnoy, René ^c   Doxiadis, Ilias I N ^a   Claas, Frans H J ^d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EUROTRANSPLANT INTERNATIONAL FOUNDATION   (Netherlands)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d Building 1 ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AZATHIOPRINE; CYCLOSPORIN; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; FEMALE; GRAFT FAILURE; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PREGNANCY; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 2342486013     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000120385.03278.28     Document Type: Article

References (12)

1. Power DA, Mason RJ, Stewart GM, et al. The fetus as an allograft: Evidence for protective antibodies to HLA-linked paternal antigens. Lancet 1983; 2: 701.
2. Suciu-Foca N, Reed E, Rohowsky C, et al. Anti-idiotypic antibodies to anti-HLA receptors induced by pregnancy. Proc Natl Acad Sci USA 1983; 80: 830.
3. Babbage SJ, Arkwright PD, Vince GS, et al. Cytokine promotor gene polymorphisms and idiopathic recurrent pregnancy loss. J Reprod Immunol 2001; 51: 21.
4. Dankers MKA, Roelen DL, Van der Meer-Prins EM, et al. Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28. Transplantation 2003; 75: 418.
5. Dankers MKA, Roelen DL, Korfage N, et al. Differential immunogenicity of paternal HLA class I antigens in pregnant women. Hum Immunol 2003; 64: 600.
6. Dankers MKA, Roelen DL, Nagelkerke NJD, et al. The HLA-DR phenotype of the responder is predictive for the humoral response against HLA class I antigens. Hum Immunol 2004; 65: 13.
7. Duquesnoy RJ. HLAMatchmaker: A molecularly based algorithm for histocompatibility determination: I. Description of the algorithm. Hum Immunol 2002; 63: 339.
8. Duquesnoy RJ, Takemoto S, De Lange P, et al. HLAMatchmaker: A molecularly based algorithm for histocompatibility determination: III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival. Transplantation 2003; 75: 884.
9. Head JR, Drake BL, Zukerman FA. Major histocompatibility antigens on trophoblast and their regulation: Implications in the maternal-fetal relationship. Am J Reprod Immunol Microbiol 1987; 15: 12.
10. Malan BI. Modulation of the humoral immune response by placental secretory factors. Am J Reprod Immunol 1996; 35: 529.
11. Guller S. The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces. Semin Reprod Endocrinol 1999; 17: 39.
12. Claas FHJ. Predictive parameters for in vivo alloreactivity. Transplant Immunol 2002; 10: 137.